News / Africa

A Step Closer to Major HIV Prevention Method

Gilead Science's Truvada combination antiretroviral pill that's taken once daily.Gilead Science's Truvada combination antiretroviral pill that's taken once daily.
x
Gilead Science's Truvada combination antiretroviral pill that's taken once daily.
Gilead Science's Truvada combination antiretroviral pill that's taken once daily.

Multimedia

Audio
Joe DeCapua
A U.S. government panel has recommended the use of a once daily pill to help prevent HIV infection. The pill has been shown to be very effective in studies. The Food and Drug Administration, the FDA, now has until June 15 to decide whether to approve the panel’s recommendation.

The Food and Drug Administration’s Antiviral Drugs Advisory Committee has endorsed the use of Truvada as a prevention method.

Mitchell Warren, head of the AIDS advocacy group AVAC, says it’s a combination pill.

“It’s made up of two different antiretrovirals – tenofovir and emtricitabine. And those two drugs had already been approved by the FDA a number of years ago individually; and then about 8 years ago they were approved as the combination drug. But all of those approvals related to the use of the drug for treating people who are already infected with HIV,” he said.

But since it now would be used as a prevention method it needs new FDA approval.

Warren said, “It’s the first time that the FDA is considering a pill for prevention of HIV. The data presented came from a number of trials looking at the potential benefit of providing this drug to HIV uninfected people, who are at high risk of HIV in hopes of preventing transmission.”

The evidence is based on trials where participants included men who have sex with men and discordant couples. That’s where one partner is infected and the other is not. The prevention method is called preexposure prophylaxis.

“If you are at risk of HIV, if you perceive yourself to be at risk, if you’re able to take this pill everyday as part of a combination of activities, including getting frequent HIV testing, you can reduce your risk of infection quite substantially. And that’s a huge step forward in adding a new option for men and women to prevent HIV,” he said.

The FDA often follows the recommendations of its advisory committees, but approval is not guaranteed. The agency must consider a number of things before deciding. One is what would the drug label say? Would it list only specific high risk groups like men who have sex with men or recommend it for both men and women?

It also must require the manufacturer – Gilead – to produce a risk evaluation and mitigation strategy. This would help ensure safe and effective use of Truvada, including extensive training for health providers and testing to ensure people are indeed HIV negative before taking the pill.

Warren says another big issue affecting Truvada is cost.

“One often hears in the United States where this is described as a $14,000 a year pill. Rarely does anyone pay that. And one of the really exciting things – when Gilead presented all of the data they actually said publically that they plan to create a patients assistance program. So if you are HIV infected and don’t have insurance, there are programs that Gilead supports to make the drug available at very low cost or in some cases even free,” he said.

The drug would be much cheaper in developing countries, possibly several hundred dollars a year. But that’s still high by developing country standards. Warren says that price could be negotiated and reduced if PEPFAR, the President’s Emergency Plan for AIDS Relief, and the Global Fund to Fight AIDS, Tuberculosis and Malaria, plan to use Truvada.

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid